Table 1.
Demographic Characteristics of the Subjects
| Factors |
Patients with Opioid Use
Disorder |
Smoking Comparison
Group |
Non-smoking
Comparison Group |
|---|---|---|---|
| Age (years) | 36.2±8.72 | 35.3±8.25 | 35.35±10.15 |
| Sex (% male) | 100 | 100 | 100 |
| Use period (year) | 9.55±6.5 | - | - |
| Use amount (gr) | 2.85±1.44 | - | - |
| Opioid-positive urine test (%) | 100 | 0 | 0 |
| Route of administration (% smoking/oral) |
60/40 | - | - |
| BMI (kg/m2) | 25.71±4.12 | 26.5±4.04 | 26.43±4.12 |
| Hb (g/dL) | 15.085 | 15.46 | 15.32 |
| Cigarette use period (year) | 14.5±6.81 | 11.15±6.76 | - |
| Cigarette use amount (pack per year) | 1.31 | 1.1 | - |
| HIV | Negative | Negative | Negative |
| HBS | Negative | Negative | Negative |
| BUN(mg/dL) | 12.9±0.67 | 14.7±.0.63 | 14.2±0.65 |
| Creatinine (mg/dL) | 0.74±0.02 | 0.86±0.04 | 0.84± |
| AST IU/L | 23.81±.6 | 26.9±1.1 | 24.4±1.5 |
| ALT IU/L | 24.2±1.9 | 28.6±1.6 | 24±1.7 |
Data are mean±SD. There was no significant difference between three groups in demographic and baseline characteristics. ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BMI, Body mass index; BUN, Blood urea nitrogen; HBS, Hepatitis B surface antigen; HIV, The human immunodeficiency virus.